Post-IPO Equity - Arcus Biosciences - May 28, 2020 Funding Round Profile - Cointime

Bitcoin $98,996.50 +1.32%
Ethereum $3,305.27 -1.31%
BNB $624.09 +0.62%
Optimism $2.12 +0.20%
Arbitrum $0.78 -0.99%
Solana $254.62 -1.28%
Polygon $0.47 +4.51%
Cosmos $7.31 +15.40%
Avalanche $39.70 +11.64%

Bitcoin $98,996.50 +1.32%
Ethereum $3,305.27 -1.31%
BNB $624.09 +0.62%
Optimism $2.12 +0.20%
Arbitrum $0.78 -0.99%
Solana $254.62 -1.28%
Polygon $0.47 +4.51%
Cosmos $7.31 +15.40%
Avalanche $39.70 +11.64%

Arcus Biosciences

company

Funding Round

Post-IPO Equity

Money Raised

$ 200M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Gilead Sciences	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 13, 2017	Series C	$ 107M	Aisling Capital,Biotechnology Value Fund,etc.	Detail
May 1, 2015	Series A	$ 49.70M	Celgene,The Column Group	Detail
Sep 1, 2016	Series B	$ 70M	Celgene,Droia Ventures,etc.	Detail
Mar 14, 2018	IPO	$ 120M		Detail